Correlation Between Beta Drugs and Cambridge Technology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Beta Drugs and Cambridge Technology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Beta Drugs and Cambridge Technology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Beta Drugs and Cambridge Technology Enterprises, you can compare the effects of market volatilities on Beta Drugs and Cambridge Technology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Beta Drugs with a short position of Cambridge Technology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Beta Drugs and Cambridge Technology.

Diversification Opportunities for Beta Drugs and Cambridge Technology

0.68
  Correlation Coefficient

Poor diversification

The 3 months correlation between Beta and Cambridge is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Beta Drugs and Cambridge Technology Enterpris in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cambridge Technology and Beta Drugs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Beta Drugs are associated (or correlated) with Cambridge Technology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cambridge Technology has no effect on the direction of Beta Drugs i.e., Beta Drugs and Cambridge Technology go up and down completely randomly.

Pair Corralation between Beta Drugs and Cambridge Technology

Assuming the 90 days trading horizon Beta Drugs is expected to generate 1.32 times more return on investment than Cambridge Technology. However, Beta Drugs is 1.32 times more volatile than Cambridge Technology Enterprises. It trades about -0.05 of its potential returns per unit of risk. Cambridge Technology Enterprises is currently generating about -0.22 per unit of risk. If you would invest  176,450  in Beta Drugs on November 27, 2024 and sell it today you would lose (12,150) from holding Beta Drugs or give up 6.89% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Beta Drugs  vs.  Cambridge Technology Enterpris

 Performance 
       Timeline  
Beta Drugs 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Beta Drugs has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in March 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Cambridge Technology 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Cambridge Technology Enterprises has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in March 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Beta Drugs and Cambridge Technology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Beta Drugs and Cambridge Technology

The main advantage of trading using opposite Beta Drugs and Cambridge Technology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Beta Drugs position performs unexpectedly, Cambridge Technology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cambridge Technology will offset losses from the drop in Cambridge Technology's long position.
The idea behind Beta Drugs and Cambridge Technology Enterprises pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Complementary Tools

Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators